Consent To Sublease Sample Contracts

Share Cite Term
Link

Embed (HTML)
Cloudera, Inc. – Consent to Sublease (March 31st, 2017)

This Consent to Sublease ("Sublease Consent") is made and entered into as of September 26, 2016, by and among 395 Page Mill LLC, a Delaware limited liability company ("Master Landlord"), Cloudera Inc., a Delaware corporation ("Sublandlord"), and Machine Zone, Inc., a Delaware corporation ("Subtenant").

Cloudera, Inc. – Consent to Sublease (January 27th, 2017)

This Consent to Sublease ("Sublease Consent") is made and entered into as of September 26, 2016, by and among 395 Page Mill LLC, a Delaware limited liability company ("Master Landlord"), Cloudera Inc., a Delaware corporation ("Sublandlord"), and Machine Zone, Inc., a Delaware corporation ("Subtenant").

CRISPR Therapeutics AG – Consent to Sublease (September 9th, 2016)

THIS CONSENT TO SUBLEASE (this Consent), dated as of May 16, 2016, is entered into by and among MIT 650 MAIN STREET LLC, a Massachusetts limited liability company (Prime Landlord), PFIZER INC., a Delaware corporation (Sublandlord) and CRISPR THERAPEUTICS, INC., a Delaware corporation (Subtenant).

Atara Biotherapeutics – Consent to Sublease (August 8th, 2016)

THIS CONSENT TO SUBLEASE ("Consent Agreement") is entered into as of May 13, 2016, by and among PR 701 GATEWAY, LLC, a Delaware limited liability company ("Landlord"), ATARA BIOTHERAPEUTICS, INC., a Delaware corporation ("Atara"), and INTREXON CORPORATION, a Virginia corporation ("lntrexon").

CRISPR Therapeutics AG – Consent to Sublease (July 27th, 2016)

THIS CONSENT TO SUBLEASE (this Consent), dated as of May 16, 2016, is entered into by and among MIT 650 MAIN STREET LLC, a Massachusetts limited liability company (Prime Landlord), PFIZER INC., a Delaware corporation (Sublandlord) and CRISPR THERAPEUTICS, INC., a Delaware corporation (Subtenant).

Audentes Therapeutics, Inc. – Consent to Sublease Agreement (June 16th, 2016)

THIS CONSENT TO SUBLEASE AGREEMENT (this Agreement) is made as of April 21, 2016, by and among BRITANNIA GATEWAY II LIMITED PARTNERSHIP, a Delaware limited partnership (Landlord), SOLAZYME, INC., a Delaware corporation (Tenant), and AUDENTES THERAPEUTICS, INC., a Delaware corporation (Subtenant).

Prothena Corporation Plc – Consent to Sublease Agreement (May 4th, 2016)

THIS CONSENT TO SUBLEASE AGREEMENT (this "Agreement") is made as of March 28, 2016, by and among HCP BTC, LLC, a Delaware limited liability company ("Landlord"), AMGEN INC., a Delaware corporation ("Tenant"), and PROTHENA BIOSCIENCES INC, a Delaware corporation ("Subtenant").

Editas Medicine, Inc. – Consent to Sublease (January 4th, 2016)

This Consent to Sublease (this "Consent") is made as of December 31, 2013, by ARE-MA REGION NO. 28, LLC, a Delaware limited liability company, having an address of 385 East Colorado Blvd., Suite 299, Pasadena, California 91101 ("Landlord"), ALNYLAM PHARMACEUTICALS, INC., a Delaware corporation, having an address of 300 Third Street, Cambridge, Massachusetts 02142 ("Tenant"), and EDITAS MEDICINE, INC., a Delaware corporation, having an address c/o Third Rock Ventures LLC, 29 Newbury Street, 3rd Floor, Boston, Massachusetts 02116 ("Sublessee") with reference to the following Recitals.

First Amendment to Consent to Sublease (November 5th, 2015)

This First Amendment to Consent to Sublease (this "Amendment") is executed as of August 28, 2015, between FSP-SUNNYVALE OFFICE PARK, LLC, a Delaware limited liability company ("Landlord"), GOOGLE INC., a Delaware corporation ("Tenant"), and JUNIPER NETWORKS, INC., a Delaware corporation ("Subtenant").

Editas Medicine, Inc. – Consent to Sublease (October 16th, 2015)

This Consent to Sublease (this Consent) is made as of December 31, 2013, by ARE-MA REGION NO. 28, LLC, a Delaware limited liability company, having an address of 385 East Colorado Blvd., Suite 299, Pasadena, California 91101 (Landlord), ALNYLAM PHARMACEUTICALS, INC., a Delaware corporation, having an address of 300 Third Street, Cambridge, Massachusetts 02142 (Tenant), and EDITAS MEDICINE, INC., a Delaware corporation, having an address c/o Third Rock Ventures LLC, 29 Newbury Street, 3rd Floor, Boston, Massachusetts 02116 (Sublessee) with reference to the following Recitals.

First Amendment to Consent to Sublease Agreement (August 11th, 2015)

THIS FIRST AMENDMENT TO CONSENT TO SUBLEASE AGREEMENT (this "First Amendment") is made as of October 1, 2013, by and among BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord"), EXELIXIS INC., a Delaware corporation ("Tenant"), and THRESHOLD PHARMACEUTICALS, INC., a Delaware corporation ("Subtenant").

Second Amendment to Consent to Sublease Agreement (August 11th, 2015)

THIS SECOND AMENDMENT TO CONSENT TO SUBLEASE AGREEMENT (this "Second Amendment") is made as of July 1, 2015, by and among BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord"), EXELIXIS INC., a Delaware corporation ("Tenant"), and THRESHOLD PHARMACEUTICALS, INC., a Delaware corporation ("Subtenant").

First Amendment to Consent to Sublease Agreement (August 11th, 2015)

THIS FIRST AMENDMENT TO CONSENT TO SUBLEASE AGREEMENT (this "First Amendment") is made as of July 1, 2015, by and among BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord"), EXELIXIS INC., a Delaware corporation ("Tenant"), and NODALITY, INC., a Delaware corporation ("Subtenant").

Consent to Sublease (June 23rd, 2015)

THIS CONSENT TO SUBLEASE (this Consent Agreement) is entered into as of June 19, 2015 (the Effective Date), by and among CA-MISSION STREET LIMITED PARTNERSHIP, a Delaware limited partnership (Landlord), SEECHANGE HEALTH MANAGEMENT LLC, a Delaware limited liability company (Sublandlord), and JAGUAR ANIMAL HEALTH, INC., a Delaware corporation (Subtenant), with reference to the following facts:

Consent to Sublease (November 12th, 2014)

THIS CONSENT TO SUBLEASE (this Consent), dated as of September 12, 2014, is entered into by and among WLC Three VI, L.L.C., a Delaware limited liability company (Landlord), MacLean Power, L.L.C., a Delaware limited liability company (Sublandlord), and Aldeyra Therapeutics, Inc., a Delaware corporation (Subtenant).

Consent to Sublease (November 10th, 2014)

This Consent to Sublease (this "Agreement") is executed as of August 18, 2014 (the "Agreement Date"), between FSP-SUNNYVALE OFFICE PARK, LLC, a Delaware limited liability company ("Landlord"), GOOGLE INC., a Delaware corporation ("Tenant"), and JUNIPER NETWORKS, INC., a Delaware corporation ("Subtenant").

Capnia, Inc. – Consent to Sublease (July 1st, 2014)

This Consent to Sublease (Consent) is dated for reference purposes the 23rd day of May, 2014 and is entered into by and among Capnia, Inc., a Delaware corporation (Tenant), Silicon Valley Finance Group, a Delaware corporation (Subtenant) and The Realty Associates Fund VII, L.P., a Delaware limited partnership (Landlord), with reference to the following recitals:

Tobira Therapeutics, Inc. – Consent to Sublease (June 23rd, 2014)

THIS CONSENT TO SUBLEASE (Agreement) is made as of October 30, 2013, by and among DWF III GATEWAY, LLC, a Delaware limited liability company (Master Landlord), ACCESIA, INC., a Virginia corporation (Tenant) and TOBIRA THERAPEUTICS, INC., a Delaware corporation (Subtenant), with reference to the following facts:

Atara Biotherapeutics – Consent to Sublease (June 20th, 2014)

This CONSENT TO SUBLEASE (this Consent) is entered into as of this 14th day of January, 2013, by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership (Landlord), as successor in interest to BMR-Bayshore Boulevard LLC, XDX, INC., a Delaware corporation (Tenant), and ATARA BIOTHERAPEUTICS, INC., a Delaware corporation (Subtenant).

Tobira Therapeutics, Inc. – Consent to Sublease (May 5th, 2014)

THIS CONSENT TO SUBLEASE (Agreement) is made as of October 30, 2013, by and among DWF III GATEWAY, LLC, a Delaware limited liability company (Master Landlord), ACCESIA, INC., a Virginia corporation (Tenant) and TOBIRA THERAPEUTICS, INC., a Delaware corporation (Subtenant), with reference to the following facts:

Atara Biotherapeutics – Consent to Sublease (April 10th, 2014)

This CONSENT TO SUBLEASE (this Consent) is entered into as of this 14th day of January, 2013, by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership (Landlord), as successor in interest to BMR-Bayshore Boulevard LLC, XDX, INC., a Delaware corporation (Tenant), and ATARA BIOTHERAPEUTICS, INC., a Delaware corporation (Subtenant).

Aquinox Pharmaceuticals, Inc – Consent to Sublease (February 28th, 2014)
Consent to Sublease Agreement (October 30th, 2013)

THIS CONSENT TO SUBLEASE AGREEMENT (this "Agreement") is made as of August 5, 2013, by and among BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord"), EXELIXIS INC., a Delaware corporation ("Tenant"), and SUTRO BIOPHARMA, INC., a Delaware corporation ("Subtenant").

Consent to Sublease (May 9th, 2013)

THIS CONSENT TO SUBLEASE (this "Consent") is made as of the 12 day of April 2013, by and among THE RECTOR, CHURCH-WARDENS AND VESTRYMEN OF TRINITY CHURCH IN THE CITY OF NEW YORK, a religious corporation, having an office at 75 Varick Street, 2nd Floor, New York, New York 10013, as landlord ("Landlord"), ALOT, INC., a Delaware corporation, having an office at 1111 Main Street, Suite 201, Conway, AR 72032, as tenant ("Tenant"), and SHOPKEEP.COM, INC., a Delaware corporation, having an office at 55 Broad Street, 9th Floor, New York, New York 10004, as subtenant ("Subtenant").

Master Landlords Consent to Sublease (May 6th, 2013)

7171 SOUTHWEST PARKWAY HOLDINGS, L.P., a Delaware limited partnership (Master Landlord), and LANTANA HP, LTD., a Texas limited partnership (Master Tenant), are Master Landlord and Master Tenant, respectively, under that certain Lease Agreement dated of even date herewith (the Master Lease), pursuant to which Master Tenant leases from Master Landlord certain premises at a suburban office/product research and development laboratory campus located at 7171 Southwest Parkway, Austin, Texas 78735 (the Property), which includes space in five separate Buildings as follows: (i) B100 containing approximately 106,275 rentable square feet; (ii) B200 containing approximately 224,734 rentable square feet; (iii) B300 containing approximately 217,798 rentable square feet; (iv) B400 containing approximately 224,922 rentable square feet; and (v) a portion of B500 containing approximately 38,621 rentable square feet and the use of Common Areas and Building Exclusive Use Common Areas (the Premises), all a

Consent to Sublease Agreement (October 27th, 2011)

THIS CONSENT TO SUBLEASE AGREEMENT (this Agreement) is made as of August 16, 2011, by and among HCP Life Science REIT, Inc., a Maryland corporation (Landlord), Exelixis Inc., a Delaware corporation (Tenant), and Nodality, Inc., a Delaware corporation (Subtenant).

Consent to Sublease Agreement (October 27th, 2011)

THIS CONSENT TO SUBLEASE AGREEMENT (this Agreement) is made as of August 19, 2011, by and among HCP Life Science REIT, Inc., a Maryland corporation (Landlord), Exelixis Inc., a Delaware corporation (Tenant), and Threshold Pharmaceuticals, Inc., a Delaware corporation (Subtenant).

Radius Health, Inc. – Consent to Sublease (September 30th, 2011)

Reference is made to that certain Lease dated June 28, 2004 and amended by First Amendment to Lease dated April 30, 2007 (as amended, the Prime Lease), by and between Broadway/Hampshire Associates Limited Partnership, a Massachusetts limited partnership, as lessor (the Lessor), and Sonos, Inc., a Delaware corporation, as lessee (the Lessee), regarding certain premises consisting of approximately (i) 5,672 rentable square feet located on the 6th floor (the 6th Floor Premises) and (ii) 5,944 rentable square feet located on the 7th floor (the 7th Floor Premises) of the building (the Building) located at 201 Broadway, Cambridge, Massachusetts, all as more particularly described in the Prime Lease (the Prime Lease Premises).

Radius Health, Inc. – Consent to Sublease (May 23rd, 2011)

Reference is made to that certain Lease dated June 28, 2004 and amended by First Amendment to Lease dated April 30, 2007 (as amended, the Prime Lease), by and between Broadway/Hampshire Associates Limited Partnership, a Massachusetts limited partnership, as lessor (the Lessor), and Sonos, Inc., a Delaware corporation, as lessee (the Lessee), regarding certain premises consisting of approximately (i) 5,672 rentable square feet located on the 6th floor (the 6th Floor Premises) and (ii) 5,944 rentable square feet located on the 7th floor (the 7th Floor Premises) of the building (the Building) located at 201 Broadway, Cambridge, Massachusetts, all as more particularly described in the Prime Lease (the Prime Lease Premises).

Aveo Pharmaceuticals – Consent to Sublease (May 12th, 2011)

THIS CONSENT TO SUBLEASE (this Consent), dated as of March 15, 2011, is entered into by and among MASSACHUSETTS INSTITUTE OF TECHNOLOGY, a Massachusetts charitable corporation with an address c/o MIT Investment management Company, 238 Main Street, Suite 200, Cambridge, MA 02142 (Prime Landlord ), ACCELERON PHARMA, INC., a Delaware corporation with an address of 128 Sidney Street, Cambridge, MA 02139 (Sublandlord) and AVEO PHARMACEUTICALS, INC., a Delaware corporation with an address of 75 Sidney Street, Cambridge, MA 02139 (Subtenant).

Consent to Sublease (November 4th, 2010)

This Consent to Sublease (this Consent) is made as of July 9, 2010, by and among ARE-SAN FRANCISCO NO. 12, LLC, a Delaware limited liability company (Landlord), EXELIXIS, INC., a Delaware corporation (Tenant), and ONYX PHARMACEUTICALS, INC., a Delaware corporation (Sublessee), with reference to the following Recitals.

Consent to Sublease (September 27th, 2010)

THIS CONSENT TO SUBLEASE (this Consent) is entered into as of the 3lst day of January, 2008, by and among TRANSWESTERN BRICKSTONE SQUARE, L.L.C., a Delaware limited liability company (Landlord), PALM, INC., a Delaware corporation (Sublandlord), and SIGE SEMICONDUCTOR, INC., a Delaware corporation (Subtenant).

Consent to Sublease (August 17th, 2010)

THIS CONSENT TO SUBLEASE (this Consent) is entered into as of the 3lst day of January, 2008, by and among TRANSWESTERN BRICKSTONE SQUARE, L.L.C., a Delaware limited liability company (Landlord), PALM, INC., a Delaware corporation (Sublandlord), and SIGE SEMICONDUCTOR, INC., a Delaware corporation (Subtenant).

Kobex Minerals Inc – Consent to Sublease (April 6th, 2010)

in any case where the Lease is terminated, surrendered or otherwise cancelled including, without limitation, a disclaimer of the Lease by a trustee in bankruptcy of the Tenant.

Poniard Pharmaecuticals, Inc. – Consent to Sublease (February 18th, 2010)

This Consent to Sublease (this Consent) is made as of February 10, 2010, by ARE-SAN FRANCISCO NO. 17, LLC, a Delaware limited liability company having an address of 385 East Colorado Blvd., Suite 299, Pasadena, California 91101 (Landlord), PONIARD PHARMACEUTICALS, INC., a Washington corporation, having an address of 750 Battery Street, Suite 600, San Francisco, California 94111 (Tenant), and VERACYTE, INC., a Delaware corporation, having an address of 7000 Shoreline Court, South San Francisco, California 94080 (Sublessee) with reference to the following Recitals.